FDA Approved: TELMISARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Telmisartan from Jubilant Cadista Pharmaceuticals Inc., confirming continued approval of this generic ARB product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)